US 9719080
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted A61KA61K38/52A61K48/0066
Quick answer
US patent 9719080 (Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/52, A61K48/0066